Greystone Associates

The Power of Insight

Market Knowledge

Biologicals

Cardiology

Disease Therapeutics

Drug Delivery

Immunology

Patient Monitoring

Wound Care

Strategic Planning

Business Development

Technology Management

Continuous Glucose Monitors

The convergence of small-scale electronics and sophisticated biocompatible product designs is giving hope for a better future to millions of diabetes patients worldwide. Continuous glucose monitors that are designed .......more

Targeted Diagnostic Imaging Agents

Driven by advances in molecular probe design and biomarker detection methodologies, new imaging agents that can improve visualization of pathologies and cellular processes are changing the practice of diagnostic medicine. The ability of this new generation of........more

Noninvasive Glucose Monitors

For diabetes patients, glucose monitoring is a way of life, a several-times-per-day routine critical to physiological health. But while the traditional finger prick method has been a standard disease management tool for decades, issues of patient compliance and the limitations of current methods in detecting short-term fluctuations in glucose levels have brought a host of companies ........more

Cholesterol Monitoring

Cholesterol Monitoring has become an essential healthcare barometer for tens of millions worldwide. Current efforts to reduce the impact of coronary heart disease and stroke focus on the identification of genetic and environmental risk factors, patient education, and monitoring cholesterol levels. The vast majority of cholesterol testing is now ........more

Patient Self- Monitoring

The ability of patients to monitor their own serum levels is deemed to be a critical tool in reducing the pathological effects of poorly controlled disease factors. For conditions other than diabetes, the vast majority of monitoring is now performed in .....more